Secure your place at the Digiday Media Buying Summit in Nashville, March 2-4
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
‘Creators as the new storytellers’: Over 10,000 apply to be part of Dick’s Sporting Goods creator program
Dick’s Sporting Goods is boosting its creator roster as it looks to play a bigger role in culture, events and social-media trends.
‘Agentic with a small a’: CMOs are adopting AI more slowly than it’s evolving
And the caution isn’t confined to large language models or flashy generative tools. It bubbles up just as clearly in decisions about agentic workflows.
Digiday+ Research: Brand marketing will be the priority in 2026, after revenues fell short of expectations
Revenues fell short of marketers’ expectations in 2025. But they’ll be working with bigger budgets in 2026, and focusing on brand marketing.